Companies: 11,342     total market cap: NZ$270.143 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Alexandria Real Estate Equities
ARE
#2303
Rank
NZ$14.54 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$84.49
Share price
-0.10%
Change (1 day)
-41.99%
Change (1 year)
๐Ÿ  Real estate
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$27.37 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's total liabilities are NZ$27.37 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alexandria Real Estate Equities - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$25.77 B-3.93%
2024-12-31NZ$26.82 B19.9%
2023-12-31NZ$22.37 B10.62%
2022-12-31NZ$20.22 B23.49%
2021-12-31NZ$16.37 B25.92%
2020-12-31NZ$13.00 B6.51%
2019-12-31NZ$12.21 B24.67%
2018-12-31NZ$9.79 B23.76%
2017-12-31NZ$7.91 B10.25%
2016-12-31NZ$7.17 B7.11%
2015-12-31NZ$6.70 B24.25%
2014-12-31NZ$5.39 B24.84%
2013-12-31NZ$4.32 B-2.53%
2012-12-31NZ$4.43 B10.15%
2011-12-31NZ$4.02 B6.36%
2010-12-31NZ$3.78 B-9.92%
2009-12-31NZ$4.20 B-28.11%
2008-12-31NZ$5.84 B42.62%
2007-12-31NZ$4.09 B30.7%
2006-12-31NZ$3.13 B41.65%
2005-12-31NZ$2.21 B26.14%
2004-12-31NZ$1.75 B48.99%
2003-12-31NZ$1.17 B-8.49%
2002-12-31NZ$1.28 B-15.12%
2001-12-31NZ$1.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$204.83 B 648.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$192.01 B 601.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$148.70 B 443.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$66.63 B 143.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$6.87 B-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$115.69 B 322.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$7.44 B-72.80%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com